| Dr Amy Rocky Brackeen, MD | |
|
4709 66th St, Lubbock, TX 79414-4877 | |
| (806) 701-5844 | |
| (806) 701-5845 |
| Full Name | Dr Amy Rocky Brackeen |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 4709 66th St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427036417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | L9108 (Texas) | Secondary |
| 207N00000X | Dermatology | L9108 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skin Cancer Institute Pllc | 6800198938 | 3 |
News Archive
Hundreds of parents whose children with autism have been abandoned by the Ontario government announced today at Queen's Park that they are intensifying their efforts to make autism therapy more accessible by training in civil disobedience, peaceful protest and other more assertive forms of advocacy.
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States.
› Verified 5 days ago
| Entity Name | Skin Cancer Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922463959 PECOS PAC ID: 6800198938 Enrollment ID: O20160107000182 |
News Archive
Hundreds of parents whose children with autism have been abandoned by the Ontario government announced today at Queen's Park that they are intensifying their efforts to make autism therapy more accessible by training in civil disobedience, peaceful protest and other more assertive forms of advocacy.
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Rocky Brackeen, MD 4709 66th St, Lubbock, TX 79414-4877 Ph: (806) 701-5844 | Dr Amy Rocky Brackeen, MD 4709 66th St, Lubbock, TX 79414-4877 Ph: (806) 701-5844 |
News Archive
Hundreds of parents whose children with autism have been abandoned by the Ontario government announced today at Queen's Park that they are intensifying their efforts to make autism therapy more accessible by training in civil disobedience, peaceful protest and other more assertive forms of advocacy.
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.
Pacific Edge Limited, a cancer diagnostics company developing and commercializing a suite of non-invasive tests for the detection and management of bladder cancer, announces today the commercial launch of the third product in the Company's Cxbladder family of products, Cxbladder Monitor, in the United States.
› Verified 5 days ago
Dr. Brent R. Paulger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2202 Ithaca Ave, Lubbock, TX 79410 Phone: 806-797-1202 Fax: 806-797-4854 | |
Dr. Bryan Harris, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3715 21st St, Lubbock, TX 79410 Phone: 806-795-0610 Fax: 806-795-0602 | |
Ashley Sturgeon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2202 Ithaca Ave, Lubbock, TX 79410 Phone: 806-797-1202 Fax: 806-797-4854 | |
Dr. Michael David Long, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6012 82nd St Ste 15, Lubbock, TX 79424 Phone: 806-749-7933 Fax: 806-749-6117 | |
Michelle Babb Tarbox, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St, Department Of Dermatology, Lubbock, TX 79430 Phone: 806-743-1842 Fax: 806-743-2933 | |
Dr. Richard H Hope, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3601 22nd St, Lubbock, TX 79410 Phone: 806-796-7193 Fax: 809-796-0034 |